Hypertension · 2007 · 21 citations · 20 references
Life SciencesImmunologyPharmacologyCell SignalingImmunopharmacologySignal TransductionCell MigrationLeukocyte RecruitmentLeukocyte TraffickingCell Migration DynamicsImmune Cell MigrationLymphocyte MigrationPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsStromal Cell-derived Factor 1 Signaling
Migration of CD4-positive lymphocytes into the vessel wall represents an important step in early atherogenesis. Telmisartan is an angiotensin type 1 receptor (AT1R) blocker with peroxisome proliferator-activated receptor (PPAR)-gamma-activating properties. The present study examined the effect of telmisartan on CD4-positive cell migration and the role of PPARgamma in this context. CD4-positive lymphocytes express both the AT1R and PPARgamma. Stimulation of CD4-positive lymphocytes with stromal cell-derived factor (SDF)-1 leads to a 4.1+/-3.1-fold increase in cell migration. Pretreatment of cells with telmisartan reduces this effect in a concentration-dependent manner to a maximal 1.6+/-0.7-fold induction at 10 mumol/L of telmisartan (P<0.01 compared with SDF-1-treated cells; n=22). Three different PPARgamma activators, rosiglitazone, pioglitazone, and GW1929, had similar effects, whereas eprosartan, a non-PPARgamma-activating AT1R blocker, did not affect chemokine-induced lymphocyte migration. Telmisartan's effect on CD4-positive lymphocyte migration was mediated through an early inhibition of chemokine-induced phosphatidylinositol 3-kinase activity. Downstream, telmisartan inhibited F-actin formation, as well as intercellular adhesion molecule-3 translocation. Transfection of CD4-positive lymphocytes with PPARgamma small interfering RNA abolished telmisartan's effect on migration, whereas blockade of the AT1R had no such effect. Telmisartan inhibits chemokine-induced CD4-positive cell migration independent of the AT1R via PPARgamma. These data provide a novel mechanism to explain how telmisartan modulates lymphocyte activation by its PPARgamma-activating properties.
20
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
Silvia Arber, Freda A. Barbayannis, Hartwig Hanser et al. · Nature · 1998 · 1.4K citations
Natural regulatory T cells control the development of atherosclerosis in mice
Hafid Ait‐Oufella, Benoı̂t L. Salomon, Stéphane Potteaux et al. · Nature Medicine · 2006 · 1.1K citations
Life Sciences, Immunology, Pathology +12
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Michael Schupp, Jürgen Janke, R. Clasen et al. · Circulation · 2004 · 710 citations